Showing 241 - 260 results of 312 for search '"gliomas"', query time: 0.05s Refine Results
  1. 241

    Circular RNA circFGFR1 Functions as an Oncogene in Glioblastoma Cells through Sponging to hsa-miR-224-5p by Qian Zhang, Shan Chen, Yingwei Zhen, Peng Gao, Zhenyu Zhang, Hao Guo, Yong Wang

    Published 2022-01-01
    “…Here, we state that circFGFR1 is elevated in glioma cells, resulting in aggravated glioma aggravated malignancy. …”
    Get full text
    Article
  2. 242

    Cuproptosis-related lncRNAs and genes: Potential markers for glioblastoma prognosis and treatment. by Yajia Chen, Jingxian Zhang, Weiqian Zheng, Hongwu Xu

    Published 2025-01-01
    “…Despite the availability of various treatment options, glioblastoma (GBM) remains an extremely aggressive form of glioma with a poor prognosis. In recent studies, regulatory cell death (RCD) has been identified as an effective mechanism to suppress glioma. …”
    Get full text
    Article
  3. 243

    Atypical Presentation of Atypical Teratoid Rhabdoid Tumor in a Child by Y. T. Udaka, K. Shayan, N. A. Chuang, J. R. Crawford

    Published 2013-01-01
    “…This case illustrates the diverse presentation of ATRT in childhood that can clinically and radiographically mimic that of low grade glioma.…”
    Get full text
    Article
  4. 244

    Insights Into the Role of Bmi‐1 Deregulation in Promoting Stemness and Therapy Resistance in Glioblastoma: A Narrative Review by Fatima Shaalan, Nissrine Ballout, Wafaa Takash Chamoun

    Published 2025-01-01
    “…Keywords and MeSH terms included the following: “glioma”, “polycomb repressive complex 1”, and “Bmi1”. …”
    Get full text
    Article
  5. 245
  6. 246

    Analysis of Wave Solutions of an Adhenovirus-Tumor Cell System by Baba Issa Camara, Houda Mokrani

    Published 2012-01-01
    “…We discuss biological background and mathematical analysis of glioma gene therapy for contributing to cancer treatment. …”
    Get full text
    Article
  7. 247

    Multimodal Imaging of Neural Progenitor Cell Fate in Rodents by Yannic Waerzeggers, Markus Klein, Hrvoje Miletic, Uwe Himmelreich, Hongfeng Li, Parisa Monfared, Ulrich Herrlinger, Mathias Hoehn, Heinrich Hubert Coenen, Michael Weller, Alexandra Winkeler, Andreas Hans Jacobs

    Published 2008-03-01
    “…We investigated C17.2 cells stably expressing herpes simplex virus type 1–thymidine kinase (HSV-1- tk ) and green fluorescent protein ( gfp ) (C17.2- tk IRES gfp = C17.2-TIG) or HSV-1- tk , gfp , and firefly luciferase ( luc ) (C17.2- luc IRES tkgfp = C17.2-LITG) and determined the detection sensitivity of positron emission tomography (PET) and bioluminescence imaging (BLI) for these cells in culture and in vivo in subcutaneous and intracranial glioma models. In addition, PET and BLI were used to further investigate and follow the fate of implanted C17.2-LITG cells in an intracranial glioma model. …”
    Get full text
    Article
  8. 248

    The Temporal Pattern of a Lesion Modulates the Functional Network Topology of Remote Brain Regions by W. De Baene, G. J. M. Rutten, M. M. Sitskoorn

    Published 2017-01-01
    “…In this study, we compared resting-state functional connectivity data of patients with a slowly growing low-grade glioma (LGG) with that of patients with a faster-growing high-grade glioma (HGG). …”
    Get full text
    Article
  9. 249

    Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation by Shoukai Yu, Lingmei Qian, Liling Xu, Jun Ma

    Published 2025-02-01
    “…Significant downregulation of SOX2 expression was observed in colorectal adenocarcinoma, esophageal carcinoma, rectum adenocarcinoma, stomach adenocarcinoma, and testicular germ cell tumors, whereas its expression was upregulated in cervical squamous cell carcinoma, glioblastoma multiforme, lower grade glioma, lung adenocarcinoma, and lung squamous cell carcinoma.Survival analysis showed that low SOX2 expression correlated with better prognosis in bladder cancer, liver hepatocellular carcinoma, kidney renal clear cell carcinoma, and sarcoma, whereas high SOX2 expression was associated with poor prognosis in lung adenocarcinoma, and lung squamous cell carcinoma, glioblastoma multiforme, lower grade glioma. …”
    Get full text
    Article
  10. 250

    Self-Assembly Iron Oxide Nanoclusters for Photothermal-Mediated Synergistic Chemo/Chemodynamic Therapy by Xiang Li, Zhen Wang, Mian Ma, Zhouqing Chen, Xiang-long Tang, Zhong Wang

    Published 2021-01-01
    “…Our SPIOCs@HSA-RGD nanoplatform showed well biocompatibility and could target glioma specifically. Photothermal conversion and ROS burst were detected after continuous 808 nm light irradiation, and a significant antitumor effect was achieved. …”
    Get full text
    Article
  11. 251
  12. 252

    Association between a Primitive Brain Tumor and Cerebral Aspergillosis by Siegfried Hélage, Charles Duyckaerts, Danielle Seilhean, Jean-Jacques Hauw, Jacques Chiras

    Published 2012-01-01
    “…A case of lethal cerebral aspergillosis in a patient with an infiltrative glioma treated with corticotherapy and radiotherapy is reported. …”
    Get full text
    Article
  13. 253

    Exploring the Therapeutic Potential of Cannabidiol in U87MG Cells: Effects on Autophagy and NRF2 Pathway by Laura Giannotti, Benedetta Di Chiara Stanca, Francesco Spedicato, Daniele Vergara, Eleonora Stanca, Fabrizio Damiano, Luisa Siculella

    Published 2024-12-01
    “…In this study, we treated U87MG glioma cells with low dose (1 μM) CBD and evaluated its molecular effects. …”
    Get full text
    Article
  14. 254
  15. 255

    Sodium valproate enhances efficacy of NKG2D CAR-T cells against glioblastoma by Junchen Liu, Junchen Liu, Kun Dai, Kun Dai, Muhammad Auwal Saliu, Muhammad Auwal Saliu, Mansur Dabai Salisu, Mansur Dabai Salisu, Jiangyu Gan, Lukman Olalekan Afolabi, Dehong Yan, Guizhong Zhang, Maoxuan Liu, Maoxuan Liu, Xiaochun Wan, Xiaochun Wan

    Published 2025-01-01
    “…NKG2D CAR-T cells have demonstrated a favorable safety profile in patients with hematologic tumors, and showed robust antitumor efficacy in various xenograft models, including glioblastoma. However, malignant glioma cells evade immunological surveillance by reducing NKG2D ligands expression or cleavage. …”
    Get full text
    Article
  16. 256

    Spinal Intradural, Extramedullary Ependymoma with Astrocytoma Component: A Case Report and Review of the Literature by Gene M. Weinstein, Knarik Arkun, James Kryzanski, Michael Lanfranchi, Gaurav K. Gupta, Harprit Bedi

    Published 2016-01-01
    “…Pathologic evaluation revealed a low grade glioma with components of both ependymoma and pilocytic astrocytoma with MUTYH G382D mutation. …”
    Get full text
    Article
  17. 257

    Changes in the organ of vision in neurofibromatosis type 1 in the developmental age by Mirosława Grałek, Katarzyna Piasecka, Katarzyna Wasyliszyn-Sieroszewska, Anna Niwald

    Published 2024-10-01
    “…Ocular manifestations mainly present as eyelid abnormalities due to hamartomas, Lisch nodules on the iris, optic glioma, and glaucoma. Diagnostics relies on clinical and imaging evaluations, as well as genetic testing. …”
    Get full text
    Article
  18. 258

    The diagnostic and prognostic significance of HOXC13-AS and its molecular regulatory mechanism in human cancer by Xiaosi Gu, Xin Hu, Sijia Zhang, Xiaoyu Zhang, Yong Wang, Lianlian Li, Lianlian Li

    Published 2025-02-01
    “…This review summarizes the clinical significance of HOXC13-AS as a biomarker for human tumor diagnosis and prognosis and outlines the function and molecular regulation mechanism of HOXC13-AS in various types of cancer, including nasopharyngeal carcinoma, breast cancer, oral squamous cell carcinoma, glioma, and cervical cancer. Overall, this review emphasizes the potential of HOXC13-AS as a human tumor predictive biomarker and therapeutic target, paving the way for its clinical application.…”
    Get full text
    Article
  19. 259

    Temozolomide-Induced Myelodysplasia by Ethan A. Natelson, David Pyatt

    Published 2010-01-01
    “…A patient who had received temozolomide (TMZ) as a single agent in treatment of malignant glioma developed therapy-induced myelodysplasia (T-MDS). …”
    Get full text
    Article
  20. 260

    Pilocytic astrocytoma: A rare case report by Harry Galuh Nugraha, PhD, Elsa Yoasta, MD, Mirna Sobana, MD, Hermin Aminah Usman, MD

    Published 2025-04-01
    “…Pilocytic astrocytoma (PA) is a rare, low-grade glioma predominantly affecting children and young adults, with a favorable prognosis and a high survival rate. …”
    Get full text
    Article